Industry Updates for the Psychedelics World | Page 6 of 35

Psychedelics News

Industry

4 Aug 2023

Affordable Ketamine Treatments: Interview With Dr. Bryan Henry of PsychMD

We sat down with PsychMD founder Bryan Henry to discuss the company’s ambitious roll-out and focus on affordable ketamine treatments....

By Microdose

Industry

3 Aug 2023

Psyence Announces SEC Registration For NASDAQ (by SPAC Merger)

Psyence announces a SPAC merger and filing with the SEC for eventual NASDAQ trading....

By Microdose NewsDesk

Industry

2 Aug 2023

Awakn Life Sciences Completes Sale of Clinics; Shifts To Biotech Development

Awakn Life Sciences has sold its last clinic and shifted its focus entirely to its clinical trials and biotech research....

By Jason Najum

Industry

27 Jul 2023

Rexis Biotech: Improving Functional Ingredients With Innovative Technology

Rexis Biotech is using new technology to change how we produce and consume consumer ingredients....

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Industry

26 Jul 2023

Wonderland Expands: Bringing Together Psychedelics, Mental Health, & Longevity

Microdose’s Wonderland conference is the premier industry event in the psychedelic medicine space - and now it's expanding into mental health and longevity....

By Jason Najum

Industry

25 Jul 2023

Positive Results Published for Compass Pathways’ COMP360 For Anorexia

A study using Compass Pathways’ COMP360 psilocybin compound for anorexia was published in Nature Medicine....

By Jason Najum

Industry

24 Jul 2023

Cybin Announces Phase 2 Dosing Completion of CYB003 Trial (Cohort 5)

Cybin announces Phase 2 cohort 5 dosing completion of CYB003 in Major Depressive Disorder...

By Microdose NewsDesk

Industry

21 Jul 2023

Bright Minds Biosciences Announces Positive Data for Phase 1 Study of BMB-101

Bright Minds Biosciences announced the successful completion of its three-part Phase 1 study of BMB-101...

By Microdose NewsDesk

Industry

19 Jul 2023

PharmaTher Announces Positive Research Results for DMT and Investment into Sairiyo Therapeutics

PharmaTher Announces Positive Research Results for PharmaPatch™ with N,N-dimethyltryptamine (DMT) and Strategic Investment into Sairiyo Therapeutics...

By Microdose NewsDesk

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result